FRI is pleased to announce that Dr. Karli Hochstatter has accepted a position as an Assistant Research Scientist with the organization. Dr. Hochstatter recently completed a Postdoctoral Research Fellowship in the HIV, Substance Abuse, and Criminal Justice T32 Fellowship Program in the School of Social Work at Columbia University. Dr. Hochstatter completed her PhD in […]
FRI is pleased to announce that Dr. Karen Alexander has accepted the position of Assistant Research Scientist at FRI. Dr. Alexander is an early career nurse scientist with a focus on improving healthcare delivery for women with opioid use disorder (OUD). Dr. Alexander has over 15 years of clinical experience as a registered nurse working with women […]
It is the pleasure of Friends Research Institute to announce that Dr. Mishka Terplan, Associate Medical Director since 2019, assumed the role of Medical Director on August 1, 2021. Dr. Terplan is board certified in Addiction Medicine and Obstetrics and Gynecology. He is a Fellow of the American Congress of Obstetricians and Gynecologists, a Distinguished […]
Friends Research Institute congratulates Dr. Cathy Reback and the entire Friends Community Center team for being the recipient of 2021 Stuart Nichols Award from the Association of LGBTQ Psychiatrists. The Stuart Nichols Award is given annually to a community organization for making a difference in the mental health of LGBTQ individuals. We at FRI acknowledge […]
Dr. Cathy Reback’s research is included in the SAMHSA intervention guide, “Prevention and Treatment of HIV among People Living with Substance Use and/or Mental Disorders.” The Alexis Project is a combined Peer Health Navigation (PHN) and Contingency Management (CM) intervention that targets HIV milestones associated with advancement along the HIV Care Continuum. Although designed for […]
Friends Research Institute (FRI) and its clinical collaborators at Chase Brexton Health Care are serving as one of the five sites in a National Institute of Drug Abuse (NIDA) Clinical Trials Network study, entitled the Subthreshold Opioid Use Disorder Prevention (STOP) trial. Research personnel at FRI will assist with the conduct of the study. The […]
FRI is pleased to announce that Dr. Ariel Ludwig has been promoted from a Research Associate to an Assistant Research Scientist, effective September 24, 2020. Since joining FRI in 2019, Dr. Ludwig has performed several qualitative analyses of research data resulting in publications ranging from the establishment of methodological best practices (in press, International Journal […]
FRI is proud to announce that Dr. Jan Gryczynski received the Most Reviewed Articles award (tied with two other reviewers) from the Journal of Addiction Medicine for peer reviewing nine papers for the Journal in 2019. This is the second time that Dr. Gryczynski has received this award. Click here to see article.
We are pleased to announce that Dr. Mishka Terplan has been promoted to serve as Associate Medical Director of Friends Research Institute. Dr. Terplan is board certified in both Obstetrics and Gynecology and Addiction Medicine. His primary research expertise lies along the intersections of reproductive and behavioral health. In addition to his work at FRI, […]
Drs. Michael Gordon, Timothy Kinlock (retired) and Robert Schwartz were cited in an April 2020 Pew Charitable Trusts report for their work on two National Institute on Drug Abuse (NIDA) funded studies involving the initiation of methadone and buprenorphine-naloxone with individuals who were currently in prison. This work was conducted in collaboration with the Maryland […]
